VICTORY CAPITAL MANAGEMENT INC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1040188
San Antonio, TX
Position in SUPN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$25,969,366
-$183,768 QoQ
Shares Held
502,406
-4.5% QoQ
Ownership
0.866%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 87.27423637456559.ToString("F0")%
Shared 0.ToString("F0")%
None 12.72576362543441.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026VICTORY CAPITAL MANAGEMENT INC holds $398,774,467 across 27 Drug Manufacturers - Specialty & Generic names. SUPN ranks #6 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
731,609 | $96,382,169 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,838,437 | $55,373,722 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
60,541 | $35,899,602 | |
| 4 | ZTS |
Zoetis Inc.
|
295,063 | $34,879,397 | |
| 5 | VTRS |
Viatris Inc
|
2,394,145 | $32,344,898 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
502,406 | $25,969,366 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
506,521 | $24,388,985 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
625,304 | $20,678,803 |
All Filings in SUPN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,969,366 | 502,406 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $26,153,134 | 526,220 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $26,754,514 | 559,835 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $23,688,635 | 751,543 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $22,024,964 | 672,518 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $25,829,847 | 714,321 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $23,162,717 | 742,871 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $19,662,266 | 735,038 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $22,097,754 | 647,838 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $19,980,118 | 690,398 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $19,606,929 | 711,169 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $19,800,552 | 658,701 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $23,938,465 | 660,736 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $24,463,841 | 685,838 | Shares | Sole | 2023-04-25 | |
| 2022-09-30 | $26,317,325 | 777,469 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $22,694,102 | 784,720 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $27,135,936 | 839,602 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $24,705,605 | 847,243 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $23,116,222 | 866,750 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $19,671,053 | 638,878 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $11,020,392 | 420,947 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $10,767,322 | 427,954 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $10,145,849 | 486,845 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $652,982 | 27,494 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $460,184 | 25,580 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||